In Brief
This article was originally published in The Tan Sheet
Executive Summary
POM, agency grilled during appeal to FTC board; Swander buys Physicians Formula; FDA again warns about Reumofan; Parrillo warned on GMPs, response; Potential botulism prompts Protica recalls; more news In Brief.
You may also be interested in...
Swanson Health Sale Could Lead Private Equity Spike In Supplement Space
Swander Pace Capital's Swanson Health deal announced Jan. 25 is the firm's second in two months in the supplement industry after acquiring Captek Softgel in December. OTC drug and supplement firms in 2016 could be among the consumer product spaces targeted in likely higher private equity investing.
Regulatory News In Brief
FDA warns Healing Ways to register facility; Dragon Herbs warned for tradeshow materials; BNE recalls ephedra-spiked supplements; supplement flu prevention claims cross the line; more regulatory news in brief.
Regulatory News In Brief
FDA warns Healing Ways to register facility; Dragon Herbs warned for tradeshow materials; BNE recalls ephedra-spiked supplements; supplement flu prevention claims cross the line; more regulatory news in brief.